ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Transvenosis
|
1.8K |
590K |
16 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.8K
|
590K
|
16
|
|
ASX - By Stock
|
SP1 |
Re:
ISX & ISXFEU
|
|
Transvenosis
|
138 |
56K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
138
|
56K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX & ISXFEU
|
|
Transvenosis
|
138 |
56K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
138
|
56K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Transvenosis
|
3.1K |
998K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
3.1K
|
998K
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
ISX & ISXFEU
|
|
Transvenosis
|
138 |
56K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
138
|
56K
|
5
|
|
ASX - By Stock
|
BRK |
Re:
Ann: SWISH Full Field Development to Grow Output & Net Income
|
|
Transvenosis
|
48 |
16K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
48
|
16K
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
ISX & ISXFEU
|
|
Transvenosis
|
138 |
56K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
138
|
56K
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
ISX & ISXFEU
|
|
Transvenosis
|
138 |
56K |
11 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
138
|
56K
|
11
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Transvenosis
|
279 |
67K |
7 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
279
|
67K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Transvenosis
|
144 |
64K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
64K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Transvenosis
|
3.1K |
998K |
17 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
3.1K
|
998K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Transvenosis
|
144 |
64K |
9 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
64K
|
9
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
7 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Transvenosis
|
279 |
67K |
8 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
279
|
67K
|
8
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
5 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
2.6K
|
874K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
Transvenosis
|
118 |
56K |
10 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
118
|
56K
|
10
|
|
ASX - By Stock
|
SP1 |
Re:
Flykk Money
|
|
Transvenosis
|
870 |
267K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
870
|
267K
|
9
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Transvenosis
|
914 |
225K |
17 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
914
|
225K
|
17
|
|
ASX - By Stock
|
BRK |
Re:
Banter and General Comments .. BRK
|
|
Transvenosis
|
11K |
3.6M |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
11K
|
3.6M
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
6 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
2.6K
|
874K
|
6
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames-Maroons Development Multi-Well Drilling Update
|
|
Transvenosis
|
7 |
3.3K |
10 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
7
|
3.3K
|
10
|
|
ASX - By Stock
|
BRK |
Re:
Banter and General Comments .. BRK
|
|
Transvenosis
|
11K |
3.6M |
1 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
11K
|
3.6M
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Transvenosis
|
279 |
67K |
8 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
279
|
67K
|
8
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Transvenosis
|
279 |
67K |
9 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
279
|
67K
|
9
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Completion of Placement and Institutional Entitlement Offer
|
|
Transvenosis
|
56 |
25K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
56
|
25K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Transvenosis
|
279 |
67K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
279
|
67K
|
8
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Transvenosis
|
914 |
225K |
7 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
914
|
225K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Transvenosis
|
914 |
225K |
7 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
914
|
225K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Transvenosis
|
279 |
67K |
7 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
279
|
67K
|
7
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Brisbane Mining Conference Presentation
|
|
Transvenosis
|
18 |
7.2K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
18
|
7.2K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Transvenosis
|
1.8K |
590K |
7 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.8K
|
590K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Transvenosis
|
1.8K |
590K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.8K
|
590K
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC Commences Proceedings Against ISX and JK
|
|
Transvenosis
|
2.6K |
874K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
2.6K
|
874K
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Transvenosis
|
914 |
225K |
8 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
914
|
225K
|
8
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames-Maroons Development Multi-Well Drilling Update
|
|
Transvenosis
|
35 |
12K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
35
|
12K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames-Maroons Development Multi-Well Drilling Update
|
|
Transvenosis
|
35 |
12K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
35
|
12K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX vs ASX
|
|
Transvenosis
|
1.8K |
754K |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1.8K
|
754K
|
10
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Transvenosis
|
914 |
225K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
914
|
225K
|
8
|
|
ASX - By Stock
|
SP1 |
Re:
ISX vs ASX
|
|
Transvenosis
|
1.8K |
754K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1.8K
|
754K
|
3
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames-Maroons Development Multi-Well Drilling Update
|
|
Transvenosis
|
35 |
12K |
4 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
35
|
12K
|
4
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames-Maroons Development Multi-Well Drilling Update
|
|
Transvenosis
|
35 |
12K |
5 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
35
|
12K
|
5
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames-Maroons Development Multi-Well Drilling Update
|
|
Transvenosis
|
35 |
12K |
8 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
35
|
12K
|
8
|
|
ASX - By Stock
|
SP1 |
Re:
Payment
|
|
Transvenosis
|
208 |
52K |
7 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
208
|
52K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
Payment
|
|
Transvenosis
|
208 |
52K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
208
|
52K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Transvenosis
|
3.1K |
998K |
20 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
3.1K
|
998K
|
20
|
|